Literature DB >> 10764711

Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease.

F F di Mola1, H Friess, Z W Zhu, A Koliopanos, T Bley, P Di Sebastiano, P Innocenti, A Zimmermann, M W Büchler.   

Abstract

BACKGROUND: Nerve growth factor (NGF), a target derived factor for survival and maintenance of peripheral and central neurones, has been implicated in several chronic inflammatory processes. AIMS: To analyse the concomitant presence of NGF and its high affinity receptor TrkA in patients undergoing surgery for Crohn's disease (CD) and ulcerative colitis (UC). PATIENTS: CD tissues were obtained from 33 patients and UC tissue samples from 12 patients undergoing surgery. Normal intestinal tissue samples were obtained from 30 individuals through an organ donor programme.
METHODS: Expression of NGF and TrkA was studied by northern blot analysis. Using in situ hybridisation and immunohistochemistry, the respective mRNA moieties and proteins were localised. Western blot analysis was used to confirm the specificity of NGF and TrkA antibodies.
RESULTS: In CD, NGF mRNA was increased in 60% (2.4-fold; p<0.01) and TrkA mRNA in 54% (1.3-fold; p<0.05) of samples. In UC, NGF mRNA expression was enhanced in 58% (2.4-fold; p<0.01) and TrkA mRNA expression in 50% (1.5-fold; p<0.05) of samples. In situ hybridisation showed that NGF and TrkA mRNA were often concomitantly present in polymorphonuclear-like cells of the lamina propria, in mast cells, and in a few ganglia of Auerbach's plexus and Meissner's plexus. Immunohistochemistry revealed that lamina propria cells and inflammatory cells (mainly mast cells) were NGF and TrkA immunopositive. NGF was also present in Meissner's plexus (especially in CD) and TrkA in enteric glia surrounding intestinal ganglia.
CONCLUSIONS: The concomitant enhanced expression of NGF and its receptor suggests activation of this pathway in chronic inflammation in CD and UC. The presence of NGF and TrkA in both neural and non-neural structures in CD and UC supports the hypothesis that neuroimmune interactions occur and are activated in both disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764711      PMCID: PMC1727937          DOI: 10.1136/gut.46.5.670

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  The myenteric plexus in regional enteritis: a study of the number of ganglion cells in the ileum in 24 cases.

Authors:  D R DAVIS; M B DOCKERTY; C W MAYO
Journal:  Surg Gynecol Obstet       Date:  1955-08

2.  Analysis of nerves in chronic pancreatitis.

Authors:  D E Bockman; M Buchler; P Malfertheiner; H G Beger
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

3.  Crohn's disease: transmission electron microscopic studies. III. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system.

Authors:  A M Dvorak; J E Osage; R A Monahan; G R Dickersin
Journal:  Hum Pathol       Date:  1980-11       Impact factor: 3.466

4.  Stimulation of connective tissue cell growth by substance P and substance K.

Authors:  J Nilsson; A M von Euler; C J Dalsgaard
Journal:  Nature       Date:  1985 May 2-8       Impact factor: 49.962

5.  Nerve growth factor and its high-affinity receptor in chronic pancreatitis.

Authors:  H Friess; Z W Zhu; F F di Mola; C Kulli; H U Graber; A Andren-Sandberg; A Zimmermann; M Korc; M Reinshagen; M W Büchler
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

6.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

Review 7.  The sensory-efferent function of capsaicin-sensitive sensory neurons.

Authors:  C A Maggi; A Meli
Journal:  Gen Pharmacol       Date:  1988

8.  An index of inflammatory activity in patients with Crohn's disease.

Authors:  P A van Hees; P H van Elteren; H J van Lier; J H van Tongeren
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

9.  Nerve growth factor: acceleration of the rate of wound healing in mice.

Authors:  A K Li; M J Koroly; M E Schattenkerk; R A Malt; M Young
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo.

Authors:  M D Boyle; M J Lawman; A P Gee; M Young
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

View more
  31 in total

Review 1.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

2.  Colitis induces calcitonin gene-related peptide expression and Akt activation in rat primary afferent pathways.

Authors:  Li-Ya Qiao; John R Grider
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

Review 3.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

4.  Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain.

Authors:  Juan M Jimenez-Andrade; Aaron P Bloom; James I Stake; William G Mantyh; Reid N Taylor; Katie T Freeman; Joseph R Ghilardi; Michael A Kuskowski; Patrick W Mantyh
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

5.  Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study.

Authors:  C M Y Lee; R K Kumar; D Z Lubowski; E Burcher
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

6.  Evaluation of the immunoreactivity of nerve growth factor and tropomyosin receptor kinase A in the esophagus of noninfected and infected individuals with Trypanosoma cruzi.

Authors:  Jacqueline Garcia Duarte; Rodolfo Duarte Nascimento; Patrícia Rocha Martins; Débora d'Ávila Reis
Journal:  Parasitol Res       Date:  2018-03-17       Impact factor: 2.289

7.  Managing pain in inflammatory bowel disease.

Authors:  Michael J Docherty; R Carter W Jones; Mark S Wallace
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

8.  Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren's syndrome.

Authors:  Sabrina Lisi; Margherita Sisto; Domenico Ribatti; Massimo D'Amore; Raffella De Lucro; Maria Antonia Frassanito; Loredana Lorusso; Angelo Vacca; Dario Domenico Lofrumento
Journal:  J Mol Med (Berl)       Date:  2014-02-21       Impact factor: 4.599

Review 9.  Neuroanatomy of lower gastrointestinal pain disorders.

Authors:  Wim Vermeulen; Joris G De Man; Paul A Pelckmans; Benedicte Y De Winter
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 10.  Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?

Authors:  Xiao-juan Xu; Liang Liu; Shu-kun Yao
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.